We demonstrated that ZJP may inhibit the proliferation and survival of HCC mainly via the regulation of EGFR/MAPK, PI3K/NF-κB, and CCND1 signaling pathways. The gene discussed is NFKB1; the disease is hepatocellular carcinoma.